$188.15
0.070.04%
À la fermeture: -
$190.20
2.051.09%
Après les heures de négociation: Nov 7, 7:59 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
NVIDIA Corp a un objectif de cours consensuel de $225.14 basé sur les évaluations de 36 analystes. Le plus élevé est $350, publié par Loop Capital le novembre 3, 2025. Le plus bas est $100, publié par Seaport Global le avril 30, 2025. Les 3 évaluations d’analystes les plus récentes ont été publiées par Goldman Sachs, Rosenblatt et Loop Capital le novembre 3, 2025, respectivement. Avec un objectif de cours moyen de $276.67 entre Goldman Sachs, Rosenblatt et Loop Capital, il existe une variation implicite de 45.46% upside pour NVIDIA Corp selon ces dernières évaluations d’analystes.
Sociétés d'analyse émettant des recommandations1
Goldman Sachs
Rosenblatt
Loop Capital
DA Davidson
UBS
1calculé à partir des notes des analystes
Notes d'analystes pour NVIDIA
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/03/2025 | 26.18% | Goldman Sachs | $210 → $240 | Maintains | Buy | |||
11/03/2025 | 26.18% | Rosenblatt | $215 → $240 | Maintains | Buy | |||
11/03/2025 | 84.02% | Loop Capital | $250 → $350 | Maintains | Buy | |||
10/29/2025 | 31.44% | DA Davidson | $210 → $250 | Maintains | Buy | |||
10/29/2025 | 23.55% | UBS | $205 → $235 | Maintains | Buy | |||
10/29/2025 | 57.73% | Cantor Fitzgerald | $300 → $300 | Reiterates | Overweight → Overweight | |||
10/29/2025 | 44.58% | B of A Securities | $235 → $275 | Maintains | Buy | |||
10/15/2025 | 68.24% | HSBC | $200 → $320 | Upgrade | Hold → Buy | |||
10/13/2025 | 18.3% | Mizuho | $205 → $225 | Maintains | Outperform | |||
10/09/2025 | 57.73% | Cantor Fitzgerald | $240 → $300 | Maintains | Overweight | |||
10/03/2025 | 26.18% | Cantor Fitzgerald | $240 → $240 | Reiterates | Overweight → Overweight | |||
09/30/2025 | 31.44% | Keybanc | $230 → $250 | Maintains | Overweight | |||
09/30/2025 | 10.41% | Citigroup | $200 → $210 | Maintains | Buy | |||
09/29/2025 | 15.67% | Jefferies | — | $205 → $220 | Maintains | Buy | ||
09/25/2025 | 26.18% | Barclays | $200 → $240 | Maintains | Overweight | |||
09/23/2025 | 10.41% | DA Davidson | $210 → $210 | Maintains | Buy | |||
09/23/2025 | 18.3% | Evercore ISI Group | $214 → $225 | Maintains | Outperform | |||
09/23/2025 | 13.04% | Rosenblatt | $215 → $215 | Maintains | Buy | |||
09/11/2025 | 10.41% | DA Davidson | $195 → $210 | Upgrade | Neutral → Buy | |||
09/08/2025 | 5.15% | Citigroup | $210 → $200 | Maintains | Buy | |||
09/04/2025 | 13.04% | JP Morgan | $215 → $215 | Maintains | Overweight | |||
08/28/2025 | 10.41% | Citigroup | $190 → $210 | Maintains | Buy | |||
08/28/2025 | 13.04% | JP Morgan | $170 → $215 | Maintains | Overweight | |||
08/28/2025 | 2.52% | DA Davidson | $135 → $195 | Maintains | Neutral | |||
08/28/2025 | 5.15% | Goldman Sachs | $200 → $200 | Reiterates | Buy → Buy | |||
08/28/2025 | 28.81% | Craig-Hallum | $195 → $245 | Maintains | Buy | |||
08/28/2025 | 18.3% | Oppenheimer | $200 → $225 | Maintains | Outperform | |||
08/28/2025 | 10.41% | Morgan Stanley | $206 → $210 | Maintains | Overweight | |||
08/28/2025 | 23.55% | B of A Securities | $220 → $235 | Maintains | Buy | |||
08/28/2025 | 10.41% | Wedbush | $210 → $210 | Reiterates | Outperform → Outperform | |||
08/28/2025 | 19.87% | Truist Securities | $210 → $228 | Maintains | Buy | |||
08/28/2025 | 26.18% | Cantor Fitzgerald | $240 → $240 | Reiterates | Overweight → Overweight | |||
08/28/2025 | 20.93% | Keybanc | $215 → $230 | Maintains | Overweight | |||
08/28/2025 | 18.3% | Bernstein | $185 → $225 | Maintains | Outperform | |||
08/28/2025 | 13.04% | Rosenblatt | $200 → $215 | Maintains | Buy | |||
08/28/2025 | 15.67% | Benchmark | $190 → $220 | Maintains | Buy | |||
08/28/2025 | 5.15% | Needham | $200 → $200 | Reiterates | Buy → Buy | |||
08/25/2025 | 11.46% | Stifel | $202 → $212 | Maintains | Buy | |||
08/25/2025 | 18.3% | Baird | $195 → $225 | Maintains | Outperform | |||
08/22/2025 | 12.51% | Evercore ISI Group | $190 → $214 | Maintains | Outperform | |||
08/21/2025 | 7.78% | UBS | $175 → $205 | Maintains | Buy | |||
08/21/2025 | 10.41% | Wedbush | $175 → $210 | Maintains | Outperform | |||
08/20/2025 | 13.04% | Keybanc | $190 → $215 | Maintains | Overweight | |||
08/19/2025 | 23.55% | TD Cowen | $140 → $235 | Maintains | Buy | |||
08/18/2025 | 26.18% | Cantor Fitzgerald | $200 → $240 | Maintains | Overweight | |||
08/18/2025 | 8.31% | Morgan Stanley | $200 → $206 | Maintains | Overweight | |||
08/14/2025 | 7.78% | Mizuho | $192 → $205 | Maintains | Outperform | |||
08/13/2025 | 18.3% | Piper Sandler | $180 → $225 | Maintains | Overweight | |||
08/11/2025 | 15.67% | Wells Fargo | $185 → $220 | Maintains | Overweight | |||
08/07/2025 | 5.15% | Goldman Sachs | $185 → $200 | Maintains | Buy | |||
08/04/2025 | 15.67% | B of A Securities | $220 → $220 | Reiterates | Buy → Buy | |||
07/30/2025 | 5.15% | Morgan Stanley | $170 → $200 | Maintains | Overweight | |||
07/16/2025 | 0.95% | Mizuho | $185 → $192 | Maintains | Outperform | |||
07/16/2025 | 5.15% | Needham | $160 → $200 | Maintains | Buy | |||
07/15/2025 | 15.67% | B of A Securities | $180 → $220 | Maintains | Buy | |||
07/15/2025 | 2.52% | DZ Bank | $160 → $195 | Maintains | Buy | |||
07/15/2025 | 23.55% | Melius Research | $205 → $235 | Maintains | Buy | |||
07/15/2025 | 5.15% | Oppenheimer | $175 → $200 | Maintains | Outperform | |||
07/10/2025 | -2.73% | Goldman Sachs | → $185 | Initiates | → Buy | |||
07/07/2025 | -0.11% | Citigroup | $180 → $190 | Maintains | Buy | |||
07/03/2025 | -2.73% | Mizuho | $170 → $185 | Maintains | Outperform | |||
06/25/2025 | 31.44% | Loop Capital | $175 → $250 | Maintains | Buy | |||
06/17/2025 | 5.15% | Barclays | $170 → $200 | Maintains | Overweight | |||
06/16/2025 | -7.99% | Oppenheimer | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/29/2025 | -5.36% | B of A Securities | $160 → $180 | Maintains | Buy | |||
05/29/2025 | 10.41% | Truist Securities | $205 → $210 | Maintains | Buy | |||
05/29/2025 | -13.25% | Raymond James | $150 → $165 | Maintains | Strong Buy | |||
05/29/2025 | -5.36% | Piper Sandler | $150 → $180 | Maintains | Overweight | |||
05/29/2025 | -10.62% | Mizuho | $168 → $170 | Maintains | Outperform | |||
05/29/2025 | -5.36% | Citigroup | $150 → $180 | Maintains | Buy | |||
05/29/2025 | -10.62% | Morgan Stanley | $160 → $170 | Maintains | Overweight | |||
05/29/2025 | -10.62% | Barclays | $155 → $170 | Maintains | Overweight | |||
05/29/2025 | -29.02% | DA Davidson | $120 → $135 | Maintains | Neutral | |||
05/29/2025 | 5.15% | Rosenblatt | $178 → $200 | Maintains | Buy | |||
05/29/2025 | -0.11% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
05/29/2025 | -15.88% | Needham | $160 → $160 | Reiterates | Buy → Buy | |||
05/22/2025 | -7.99% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
05/14/2025 | -15.88% | B of A Securities | $150 → $160 | Maintains | Buy | |||
05/12/2025 | -7.99% | UBS | $180 → $175 | Maintains | Buy | |||
04/30/2025 | -47.42% | Seaport Global | → $100 | Initiates | → Sell | |||
04/25/2025 | -15.88% | Morgan Stanley | $162 → $160 | Maintains | Overweight | |||
04/23/2025 | -6.41% | Rosenblatt | $200 → $178 | Maintains | Buy | |||
04/22/2025 | -18.51% | Barclays | $175 → $155 | Maintains | Overweight | |||
04/17/2025 | -5.36% | UBS | $185 → $180 | Maintains | Buy | |||
04/16/2025 | -0.11% | Evercore ISI Group | $190 → $190 | Reiterates | Outperform → Outperform | |||
04/16/2025 | 5.15% | Rosenblatt | $220 → $200 | Maintains | Buy | |||
04/16/2025 | -36.91% | DA Davidson | $120 → $120 | Maintains | Neutral | |||
04/16/2025 | -21.14% | Raymond James | $170 → $150 | Maintains | Strong Buy | |||
04/16/2025 | 5.15% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
04/16/2025 | -21.14% | Piper Sandler | $175 → $150 | Maintains | Overweight | |||
04/16/2025 | -7.99% | Wedbush | $175 → $175 | Reiterates | Outperform → Outperform | |||
04/16/2025 | -15.88% | B of A Securities | $200 → $160 | Maintains | Buy | |||
04/14/2025 | -36.91% | DA Davidson | $125 → $120 | Maintains | Neutral | |||
04/11/2025 | -21.14% | Citigroup | $163 → $150 | Maintains | Buy | |||
04/09/2025 | -26.39% | TD Cowen | $175 → $140 | Maintains | Buy | |||
03/20/2025 | -34.28% | DA Davidson | $135 → $125 | Maintains | Neutral | |||
03/20/2025 | -0.11% | Benchmark | $190 → $190 | Reiterates | Buy → Buy | |||
03/19/2025 | -5.36% | Susquehanna | $180 → $180 | Maintains | Positive | |||
03/19/2025 | 5.15% | Cantor Fitzgerald | $200 → $200 | Reiterates | Overweight → Overweight | |||
03/19/2025 | — | Keybanc | — | Reiterates | Overweight → Overweight |
FAQ
Quel est le cours indicatif de l'action NVIDIA (NVDA) ?
Le dernier objectif de prix pour NVIDIA (NASDAQ:NVDA) a été rapporté par Goldman Sachs le novembre 3, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $240.00 s'attendant à ce que NVDA se rise dans les 12 prochains mois (un possible changement de 26.18% upside). 100 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour NVIDIA (NVDA) ?
La dernière note d'analyste pour NVIDIA (NASDAQ:NVDA) a été fournie par Goldman Sachs, et NVIDIA maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour NVIDIA (NVDA) ?
La dernière amélioration pour NVIDIA Corp a eu lieu le octobre 15, 2025 lorsque HSBC a augmenté leur objectif de prix à $320. HSBC avait précédemment a hold pour NVIDIA Corp.
Quand a eu lieu la dernière dégradation pour NVIDIA (NVDA) ?
Il n'y a pas de dernière réduction pour NVIDIA.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour NVIDIA (NVDA) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de NVIDIA, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour NVIDIA a été déposée le novembre 3, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 3, 2026.
La note d'analyste pour NVIDIA (NVDA) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de NVIDIA (NVDA) était un maintenu avec un objectif de prix de $210.00 à $240.00. Le prix actuel de NVIDIA (NVDA) est de $190.20, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.